A Clinical Trial Saved My Life
A clinical trial of tumor‑infiltrating lymphocyte therapy was successful in treating my stage IV cholangiocarcinoma.
I was diagnosed with stage IV intrahepatic cholangiocarcinoma and, after conventional therapy failed to control my disease, I enrolled in a federally funded clinical trial of tumor‑infiltrating lymphocyte (TIL) therapy led by Steven A. Rosenberg at the National Cancer Institute. Following surgical removal of lung metastases and infusion of TILs supported by high‑dose interleukin‑2, my tumors in the lungs and liver shrank and remained stable for several years, ultimately leading to complete radiologic remission. This experience saved my life and spurred my advocacy work for cholangiocarcinoma patients.
The case illustrates that even in late‑stage, traditionally untreatable cancers such as cholangiocarcinoma, experimental cellular immunotherapies can achieve durable disease control when conventional chemotherapy fails. It highlights the importance of clinical trials in providing access to innovative treatments, guiding patient advocacy, and influencing future research priorities for rare malignancies.
Bizonyítékszint: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.
Kapcsolódó jelek
- The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
- Scientists build cell line atlas of deadly cancers of the bile ducts and gallbladder
- Cholangiocarcinoma Workup: Laboratory Studies, Imaging Studies, Procedures
- New EASL Clinical Practice Guidelines on extrahepatic cholangiocarcinoma
- An open‑label study of pemigatinib in cholangiocarcinoma: final results from FIGHT‑202